New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
08:36 EDTPTCTPTC Therapeutics named a new top pick at Credit Suisse
Credit Suisse said PTC Therapeutics is a new top pick following the recent CHMP recommendation. The firm expects PTC to launch Translarna in the EU in 2H and and views it as a potential billion-dollar drug. Shares are Outperform rated with a $40 price target.
News For PTCT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
08:08 EDTPTCTPTC Therapeutics Translarna granted orphan designation in U.S., EU
Subscribe for More Information
December 18, 2014
06:35 EDTPTCTPTC Therapeutics initiated with a Buy at Citigroup
Subscribe for More Information
December 12, 2014
12:02 EDTPTCTPTC Therapeutics Translarna granted orphan drug designation
Subscribe for More Information
December 9, 2014
12:15 EDTPTCTPTC Therapeutics mentioned positively by dealReporter
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use